A detailed history of Cynosure Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cynosure Management, LLC holds 1,536 shares of VRTX stock, worth $771,763. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,536
Previous 1,513 1.52%
Holding current value
$771,763
Previous $632,000 13.77%
% of portfolio
0.12%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $9,034 - $11,167
23 Added 1.52%
1,536 $719,000
Q1 2024

May 10, 2024

BUY
$407.69 - $446.08 $616,834 - $674,919
1,513 New
1,513 $632,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cynosure Management, LLC Portfolio

Follow Cynosure Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cynosure Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cynosure Management, LLC with notifications on news.